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Abstract
Background: Acanthus montanus (Nees) T. Anderson (Acanthaceae) is a shrub widespread in
Africa, the Balkans, Romania, Greece and Eastern Mediterranean. It is used in African traditional
medicine for the treatment of urogenital infections, urethral pain, endometritis, urinary disease,
cystitis, leucorrhoea, aches and pains. In southeastern Nigeria, the root is popular and acclaimed
highly effective in the treatment of furuncles. This study was undertaken to experimentally evaluate
the antimicrobial and anti-inflammatory properties of the root extract as well as its effect on
phagocytosis and specific cell-mediated immune response which may underlie the usefulness of the
roots in treatment of furuncles.
Methods: The aqueous root extract (obtained by hot water maceration of the root powder) was
studied for effects on the growth of clinically isolated strains of Pseudomonas aeruginosa and
Staphylococcus aureus. The anti-inflammatory activity was investigated using acute topical edema of
the mouse ear induced by xylene, acute paw edema induced by agar in rats, formaldehyde arthritis
in rats, vascular permeability induced by acetic acid in mice and heat- and hypotonicity-induced
haemolysis of ox red blood cells (RBCs). Also evaluated were the effects on in vivo leukocyte
migration induced by agar, phagocytic activity of macrophages on Candida albicans and specific cell-
mediated immune responses (delayed type hypersensitivity reaction (DTHR) induced by sheep red
blood cell (SRBC)). The acute toxicity and lethality (LD50) in mice and phytochemical constituents
of the extract were also determined.
Results: The extract moderately inhibited the growth of the test organisms and significantly (P <
0.05) inhibited (57%) topical acute edema in the mouse ear. It significantly (P < 0.05) suppressed
the development of acute edema of the rat paw in a non-dose-related manner and was not effective
in inhibiting the global edematous response to formaldehyde arthritis. It also inhibited vascular
permeability induced by acetic acid in mice and the haemolysis of ox RBCs induced by heat- and
hypotonicity. The extract increased total leukocyte and neutrophil counts and caused a significant
(P < 0.05) dose-related increase in the total number of macrophages at the 800 mg/kg dose. On
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phagocytic activity, the extract evoked a significant (P  < 0.05) increase in the number of
macrophages with ingested C. albicans at 800 mg/kg dose, and significantly (P < 0.05) inhibited
DTHR in a dose-related manner. Phytochemical tests on the extract revealed an abundant
presence of alkaloids and carbohydrates while saponins, glycosides, and terpenoids occurred in
trace amounts. Acute toxicity test established an oral and intraperitoneal LD50 greater than 5,000
mg/kg.
Conclusion: The effectiveness of the root of A. montanus in the treatment of furuncles may largely
derive from mobilization of leukocytes to the site of the infection and activation of phagocytic
activity as well as suppression of exacerbated immune responses by its constituents. Antimicrobial
and anti-inflammatory activities are likely contributory mechanisms. Phytochemical constituents
such as alkaloids and carbohydrates may be responsible for these pharmacological activities.
Background
Acanthus montanus (Nees) T. Anderson (Acanthaceae),
also known as "Bear's breeches", "Mountain thistle" or
"Alligator plant", is a striking small shrub with sparse
branches and soft stem. The morphology has been
described [1]. It grows wild in grasslands, woods, scrub
and rocky hills of the Balkans, Romania, Greece, Eastern
Mediterranean and Africa [1].
A. montanus is popular in southern Nigeria where it is var-
iously called "Elele-nyijuo", "Agamsoso" and "Agameru"
and employed in traditional medicine [2]. In the Demo-
cratic Republic of Congo, the leaves are pounded in water
with those of Ananas comosus and Costus spp and used to
treat urogenital infections, urethral pain, endometritis,
urinary disease, cystitis, leucorrhoea [3]. The roots are also
used for bathing to relieve aches and pains [4]. Docu-
mented evidence of pharmacological activities shows that
the leaves of the plant possess spasmolytic [5], analgesic
[6], anti-inflammatory and antipyretic [7] properties. The
isolation of constituents such as saponins [8] and the
gammaceranes- acanthusol and its 3-O-β-D-glucopyrano-
side [9] from the plant has been documented.
In southeastern Nigeria, the root poultice is popularly
used by the Igede people of Benue State [10] and Enugu-
Ezike community of Enugu State to treat furuncles. Furun-
cle, also known as boil represents the commonest exam-
ple of an abscess, and pyogenic organisms such as
Staphyloccocus aureus, and Pseudomonas aeruginosa have
been implicated as causal agents [11]. In local use, the
root poultice is believed to cause "boil ripening", a lay
expression for enhancement of pus accumulation in the
boil thought to indicate that the infection has been sur-
mounted. Pharmacologically however, pus accumulation
is an evidence of infection by pyogenic micro organisms
and activation of cellular immune responses. Infection by
these organisms evokes the acute inflammatory response,
causing tissue swelling and the associated pain [12] and
leading to pyogenic or suppurative inflammation. In
addition to pyogenic or suppurative inflammation, these
bacteria produce potent exotoxins which affect all types of
cells and promote considerable emigration of neutrophil
polymorphs, resulting in formation of pus [11], a mixture
of necrotic tissues, dead neutrophils and macrophages
[13] the necrosis being a consequence of tissue digestion
by neutrophils [11]. These cells contribute to non-specific
defense of the body by phagocytosing and killing infect-
ing organisms [14]. Discharge of pus from a ruptured boil
restores the flow of exudates (earlier suppressed by pres-
sure from accumulated pus) and hence the defense mech-
anisms leading to elimination of infection and
commencement of healing [11]. From the pathophysiol-
ogy, it is evident that the medicinal potency of an agent
with such a popular use and acclaimed effectiveness in the
treatment of furuncles may derive from direct inhibition
of the growth of the causal organisms, suppression of
acute inflammatory response and or enhancement of the
host's ability to combat the infection through stimulation
of immune responses. This study was undertaken to eval-
uate the effect of roots of this plant on the growth of
causal organisms of furuncles and the inflammatory
response as well as cell-mediated immune responses.
Methods
Plant material
Fresh roots of A. montanus were collected in February 2005
from Nsukka, Enugu State, Nigeria and authenticated by
Mr. A. Ozioko of Bioresources Development and Conser-
vation Program (BDCP) Centre, Nsukka where a voucher
specimen (BDCP No. 308) is maintained. The plant mate-
rial was cleaned, cut into smaller pieces, dried under the
sun and reduced to a coarse powder using a Hammer Mill
(Gallenkamp, USA). The powdered plant material (900 g)
was extracted by macerating in hot water for 1 h. The
extract was strained with a muslin cloth, allowed to cool
and filtered. The filtrate was freeze dried to obtain 191.4 g
(21.3% w/w) of aqueous extract (AE) which was subse-
quently subjected to phytochemical analysis using con-
ventional methods [15].BMC Complementary and Alternative Medicine 2008, 8:27 http://www.biomedcentral.com/1472-6882/8/27
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Pharmacological tests
Animals
Adult Swiss albino rats (150–250 g) and mice (15–30 g)
of both sexes were obtained from the Laboratory Animal
Facility of the Department of Pharmacology and Toxicol-
ogy, Faculty of Pharmaceutical Sciences, University of
Nigeria, Nsukka (UNN). Animals were housed in steel
cages within the facility under standard conditions and
allowed free access to standard pellets and water. Prior to
their use, they were allowed two weeks for acclimatization
within the work area environment. A healthy male sheep
(for collection of sheep erythrocytes used for induction of
DTHR) was taken from the herd at the Faculty of Veteri-
nary Medicine, UNN. All animal experiments were in
compliance with the National Institute of Health Guide
for Care and Use of Laboratory Animal (Pub No. 85-23,
revised 1985).
Acute toxicity and lethality test
The acute toxicity and lethality (LD50) of AE in mice (n =
12) was estimated using the method described by Lorke
[16]. In stage one of the test, animals received oral admin-
istration of one of 10, 100, or 1000 mg/kg (n = 3) of AE
and observed for 24 h for number of deaths. Since no
death occurred in any of the groups in the first stage of the
test, 1600, 2900 and 5000 mg/kg doses of the extract were
administered to a fresh batch of animals (n = 1) and no
death was recorded within 24 h. A repeat of the test with
a fresh batch of animals using the intraperitoneal route
also gave the same result. Thus, the oral and ip LD50 in
mice was found to be greater than 5000 mg/kg.
Antimicrobial activity test
The inhibitory effect of AE on the growth of strains of
Pseudomonas aeruginosa and Staphylococcus aureus clinically
isolated from wounds and identified as earlier described
[17] was studied using the cup-plate diffusion method
[18]. Briefly, sterile molten agar (20 ml) was seeded with
0.1 ml of standardized broth culture of bacteria (1 × 106
CFU/ml). When set, four drops (0.02 ml per drop) of each
concentration (3.125, 6.2, 12.5, 25, 50, and 100 mg/ml)
of the extract were placed in wells (n = 5/plate) bored on
the agar by means of a sterile cork borer (6 mm diameter).
The plates (n = 5 per test organism) were incubated at
37°C for 24 h after which the inhibition zone diameter
(IZD) of each concentration of the extract was measured.
Distilled water or gentamicin (0.7 mg/ml) was used as
control.
Topical acute edema of the mouse ear
The effect of AE on acute topical inflammation was evalu-
ated by a modification of the methods of Tubaro et al [19]
and Atta and Alkofahi [20]. Adult Swiss albino mice
(15–25 g) of either sex were divided into three groups of
10 animals. The treatment group received AE (5 mg/ear)
applied on the anterior surface of the right ear. Topical
inflammation was instantly induced on the posterior sur-
face of the same ear by application of xylene (0.05 ml).
Control animals received either distilled water or
indomethacin (5 mg/ear). Two hours after induction of
inflammation, mice were killed by overdose of ether
anesthesia and both ears removed. Circular sections (7
mm diameter) of both the right (treated) and left
(untreated) ears were punched out using a cork borer, and
weighed. Edema was quantified as the weight difference
between the two earplugs. The anti-inflammatory activity
was evaluated as percent edema reduction/inhibition in
the treated animals relative to control animals [19,21]
using the relation;
Edema reduction/inhibition (%) = 100 [(Rt-Lt)/(Rc-Lc)]
Where Rt = mean weight of right ear plug of treated ani-
mals; Lt = mean weight of left ear plug of treated animals;
Rc = mean weight of right ear plug of control animals; Lc =
mean weight of left earplug of control animals.
Systemic acute edema of the rat paw
The rat paw edema method [22] was used. Acute inflam-
mation was measured in terms of change in volume of the
rat hind paw [23] induced by subplantar injection of agar
[24,25]. Animals (n = 5/group) received 200, 400 or 800
mg/kg of AE administered orally. Edema was induced one
hour later with agar (0.1 ml) injected into the subplantar
region of the right hind paw of the rats. The volume of dis-
tilled water displaced by the treated paw was measured
before and 1, 2, 3, 4, and 5 h after induction of edema.
Control groups received either equivalent volume of the
vehicle (distilled water) or indomethacin (100 mg/kg).
Inflammation was assessed as the difference between the
zero time volume of the treated paw (Vo) and the volume
at the various times (Vt) after the administration of the
phlogistic agent. Percent inhibition of edema [26,27] was
calculated using the relation: Inhibition of edema (%) =
100 [1-{(a-x)/(b-y)}]
Where a = mean paw volume of treated rats at various
time after egg albumin injection; x = mean paw volume of
treated rats before albumin injection; b = mean paw vol-
ume of control rats at various time after egg albumin
injection; y = mean paw volume of control rats before
albumin injection.
Formaldehyde arthritis test
The effect of the extract on chronic inflammation was
assessed using arthritis induced by formaldehyde [28] in
rats. On day one, adult Swiss albino rats of either sex
received the aqueous extract (200, 400 or 800 mg/kg)
administered orally. One hour later, arthritis was induced
by subplantar injection of 0.1 ml of 2.5% formaldehydeBMC Complementary and Alternative Medicine 2008, 8:27 http://www.biomedcentral.com/1472-6882/8/27
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solution and repeated on day 3. Arthritis was assessed by
measuring the volume of distilled water displaced by the
paw before induction of arthritis and once every day for
ten days, starting from day one, after induction of arthri-
tis. Extract administration was continued once daily for
ten days. Control animals received either indomethacin
(50 mg/kg) or equivalent volume of vehicle (distilled
water). The global edematous response was quantified as
the area under the curve (AUC) of the time-course of the
arthritic event. The AUC was calculated using the trapezoi-
dal rule. The level of inhibition of arthritis was calculated
using the relation: Inhibition of arthritis (%) = [1 - (AUCt/
AUCc)] 100
Where AUCc = AUC of the control group; AUCt = AUC of
the treated group
Vascular permeability in mice
The effect of the extract on vascular permeability was
assessed in mice using the method of Whittle [29]. Briefly,
one hour after oral administration of AE (200 or 400 mg/
kg), Evans Blue dye (0.2 ml of a 0.25% solution in Nor-
mal saline) was intravenously administered through the
tail vein. Control animals received either indomethacin
(50 mg/kg) or equivalent volume of vehicle (distilled
water). Thirty minutes later, animals received intraperito-
neal injection of 1 ml/100 g of acetic acid (0.6% v/v).
Treated animals were sacrificed 30 min after acetic acid
injection and the peritoneal cavity washed with normal
saline (3 ml) into heparinized tubes and centrifuged. The
dye content in the supernatant was measured at 610 nm
using Spectronic 21D (Milton Roy) spectrophotometer.
Membrane stabilization activity
(i) Preparation of erythrocyte suspension
Fresh whole ox blood (10 ml) was collected, transferred to
heparinized centrifuge tubes, centrifuged at 3000 rpm for
5 min, and washed three times with equal volume of nor-
mal saline. The volume of the blood was measured and
reconstituted as a 40% (v/v) suspension with isotonic
buffer solution (10 mM sodium phosphate buffer pH
7.4). The composition of the buffer solution (g/L) was
NaH2PO4 (0.2), Na2HPO4 (1.15) and NaCl (9.0) [30].
(ii) Heat induced haemolysis
The isotonic buffer solution (5 ml) containing 200 and
400 μg/ml of the aqueous extract were put in 4 sets (per
concentration) of centrifuge tubes. Control tubes con-
tained 5 ml of the vehicle or 5 ml of 100 ug/ml of hydro-
cortisone. Erythrocyte suspension (0.05 ml) was added to
each tube and gently mixed. A pair of the tubes was incu-
bated at 54°C for 20 min in a regulated water bath. The
other pair was maintained at 0–4°C in a freezer for 20
min. At the end of the incubation, the reaction mixture
was centrifuged at 1300 g for 3 min and the absorbance
(OD) of the supernatant measured at 540 nm using Spec-
tronic 2ID (Milton Roy) spectrophotometer. The level of
inhibition of hemolysis was calculated using the relation
[30]: Inhibition of hemolysis (%) = 100 [1-{(OD2-OD1)/
(OD3-OD1)}]
Where OD1 = absorbance of test sample unheated; OD2 =
absorbance of test sample heated; OD3 = absorbance of
control sample heated
(iii) Hypotonicity-induced haemolysis
The hypotonic solution (distilled water) (5 ml) contain-
ing 200 or 400 μg/ml of AE was put in 2 pairs (per dose)
of centrifuge tubes. Control tubes contained 5 ml of the
vehicle (distilled water) or hydrocortisone (0.5 mg/5 ml).
Erythrocyte suspension (0.05 ml) was added to each tube
and after gentle mixing, the mixtures were incubated for 1
h at room temperature (31°C). After incubation, the reac-
tion mixture was centrifuged for 3 min at 1300 g and the
absorbance (OD) of the supernatant measured at 540 nm
using Spectronic 21D (Milton Roy) spectrophotometer.
The inhibition (%) of haemolysis was calculated using the
relation [30]:
Inhibition of haemolysis (%) = 100 [1-{(OD2-OD1)/
(OD3-OD1)}]
Where OD1 = absorbance of test sample in isotonic solu-
tion; OD2 = absorbance of test sample in hypotonic solu-
tion; OD3  = absorbance of control sample hypotonic
solution
Leukocyte migration induced by inflammatory stimulus
The effect of AE on leukocyte migration in vivo was stud-
ied in rats using the method described by Ribeiro et al.
[31]. Adult albino rats (150–210 g) of either sex were
used. The extract was administered orally at 200, 400, or
800 mg/kg to animals (n = 5/dose). One hour after drug
administration, animals received intraperitoneal injection
of 1 ml of 2.8% w/v agar. Four hours later, the animals
were sacrificed and the peritoneal cavities washed with 5
ml of phosphate buffer saline containing 0.5 ml of 10%
EDTA. Total and differential leukocyte counts in the peri-
toneal wash were taken and the level of inhibition (%) or
otherwise of neutrophil and lymphocyte migration was
calculated.
Macrophage phagocytic activity
The effect of the extract on phagocytic activity of mice
peritoneal macrophages was studied using the methods
described by Rege and Dahanukar [32] and Handel-Fern-
andez and Lopez [33].BMC Complementary and Alternative Medicine 2008, 8:27 http://www.biomedcentral.com/1472-6882/8/27
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(i) Harvesting of mice peritoneal macrophages
Mice selected without sex discrimination were sensitized
by intraperitoneal administration of 0.1 ml of 50% pep-
tone. Treated animals received once daily oral administra-
tion of AE (200, 400 or 800 mg/kg) for four days. Control
animals received distilled water or metronidazole (300
mg/kg). On day four, the animals were sacrificed, and the
peritoneal macrophages collected in 10 ml of Hank's solu-
tion. The cells were washed by centrifuging at 3000 g for
10 min, and re-suspended in Minimum Enrichment
Medium [32].
(ii) Preparation of Candida albicans suspension
Laboratory strains of C. albicans were collected in loops
from cultures that were at least 3 days old and had entered
the yeast phase. The organisms were washed twice by cen-
trifuging at 2000 g for 10 min in 0.9% saline and a third
time in PBS [33].
(iii) Macrophage phagocytic activity assay
An assay system containing C. albicans suspension (0.1
ml), macrophage suspension (0.3 ml), DMEM (0.3 ml)
and Fetal Bovine Serum (0.1 ml) was incubated in a car-
bon dioxide environment at 37°C for 1.5 h. After incuba-
tion, the assay samples were smeared on microscope
slides, fixed with ethanol and stained with 10% Giemsa in
PBS for 5 min. The slides were washed, air-dried and
viewed in a light microscope (×100) under oil of immer-
sion [32]. The number of macrophages with and without
ingested C. albicans was calculated per high power field.
Phagocytic activity was assessed in terms of the propor-
tion of macrophages that ingested C. albicans versus free
and total macrophage count [34].
Delayed type hypersensitivity reaction induced by sheep 
red blood cells in rats
The effect of AE on specific cell-mediated immune
responses was evaluated using the delayed hypersensitiv-
ity reaction (DTHR) induced by sheep red blood cells
(SRBC) in rats.
(i) Preparation of sheep erythrocytes
Fresh sheep blood (10 ml) was aseptically withdrawn
from the jugular vein of a healthy male sheep and trans-
ferred to heparinized tube. The blood samples were cen-
trifuged at 3000 g for 3 min and the pellets washed with
equal volume of pyrogen-free normal saline. At the last
washing, the red blood cell count (7.3 × 106 cells/ml) was
taken.
(ii) Delayed type hypersensitivity reaction (DTHR) test
The method of Doherty [35] was used. Adult Swiss albino
rats (110–210 g) of either sex were divided into 5 groups.
Each group (n = 4) received 200, 400 or 800 mg/kg of AE
administered orally. Control animals received either
Levamisole (2.5 mg/kg) [36] or distilled water. On day
zero, one hour after AE administration, the rats were sen-
sitized by injecting fresh SRBCs (0.1 ml of 7.3 × 106 cells/
ml) intradermally into the right hind foot paw. Extract
administration was continued once daily for 7 days. On
day 7, the sensitized animals were challenged by intrader-
mal injection of SRBCs (0.1 ml) into the paw of the left
hind foot. The paw size was determined by the volume of
distilled water displaced by the paw before and 24 h after
challenge. Edema formation was quantified as the differ-
ence in the volume of the inflamed paw. The level of inhi-
bition of edema formation was calculated using the
relation:
Where a = mean paw volume of treated rats after sheep red
blood cells challenge; x = mean paw volume of treated rats
before sheep red blood cells challenge; b = mean paw vol-
ume of control rats after sheep red blood cells challenge;
y = mean paw volume of control rats before sheep red
blood cells challenge.
Statistical analysis
Data obtained was analyzed using One Way ANOVA and
further subjected to LSD post hoc test. Results are
expressed as Mean ± SEM. Difference between Means of
treated and control groups was considered significant at P
< 0.05.
Results
Effect of the extract on microbial growth
The extract inhibited the growth of both test organisms
only at 50 and 100 mg/ml. The inhibitory effect of the
extract was however, lower than that of gentamicin (0.7
mg/ml) (Table 1).
Effect of the extract on topical acute edema
Topical application of the extract significantly (P < 0.05)
inhibited edema induced by xylene in the mouse ear pro-
voking an inhibitory effect as high as 57%. The same dose
of indomethacin used as the reference drug caused 66.7%
inhibition (Table 2).
Effect of the extract on systemic acute edema
Oral administration of the extract significantly (P < 0.05)
suppressed the development of acute edema of the rat
paw induced by agar at the 3 doses tested. The extract
evoked a non-dose-related effect with the lowest dose
(200 mg/kg) exhibiting the highest inhibition which was
also better than that of indomethacin (100 mg/kg) (Table
3).
Inhibition of edema (%) 100 1 (
a-x
b-y
=− )
⎡
⎣
⎢
⎤
⎦
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Effect of the extract on chronic inflammation of the 
formaldehyde arthritis
Daily oral administration of the extract effectively sup-
pressed the early stage of development of formaldehyde
arthritis (data not shown). However, the extract was not
effective in inhibiting the later stages of the arthritis event
and hence did not reduce the global edematous response
due to arthritis (Table 4).
Effect of the extract on vascular permeability
Oral administration of the extract evoked a mild dose-
related inhibition of vascular permeability experimentally
induced by acetic acid in mice. Indomethacin exhibited a
greater inhibition than 400 mg/kg dose of the extract
(Table 5).
Effect of the extract on membrane stabilization
The extract protected the erythrocytes against heat- and
hypotonicity-induced haemolysis in a concentration-
related manner. The protective effect was greater on
haemolysis induced by heat than that caused by hypoto-
nicity (Table 6).
Effect of the extract on cell migration
Oral administration of the extract increased total leuko-
cyte and neutrophil counts at both dose levels. However,
the cell counts decreased in a dose-related manner (Table
1). The extract also caused a dose-related increase in the
macrophage count that was significant (P < 0.05) at the
800 mg/kg dose (Table 7).
Effect of the extract on phagocytosis
The extract caused a dose-related increase in the number
(and proportion) of macrophages with ingested C. albi-
cans. The increase was significant (P < 0.05) at the 800 mg/
kg dose. It also reduced the proportion of free cells in a
dose-related manner (Table 8).
Effect of the extract on SRBC-induced DTHR
The extract significantly (P  < 0.05) inhibited DTHR
induced by SRBCs in rats in a dose-related manner. The
magnitude of inhibition evoked by the extract was higher
than that exhibited by levamisole (Table 9).
Discussion
Furuncles or boils develop as a consequence of bacterial
infection and treatment with antimicrobial agents eases
the discomfort by eradicating the causal organism. Assess-
ment of the antimicrobial effect of A. montanus showed
that the aqueous root extract demonstrated moderate
antimicrobial activity against clinically isolated strains of
P. aeruginosa and S. aureus, the causal organisms mostly
implicated in boils [11]. The effect of the extract was
higher against S. aureus than P. aeruginosa which is an
indication of greater susceptibility of the former impli-
cated as the major causal organism of boils [11]. However,
the magnitude of the antimicrobial activity seems not to
suggest that the roots derive their acclaimed potency in
treatment of furuncles from antimicrobial effect.
Although treatment of boils with antimicrobial agents
may be curative in this instance (depending on the size of
the boil), anti-inflammatory agents provide instant relief
from the pain and other discomfort caused by the inflam-
matory reactions invoked by the causal organisms. Our
study showed that topical and systemic administration of
the extract resulted to inhibition of the development of
acute edema. Topical application of the extract is consist-
ent with traditional use and the relief obtained in the
treatment of boils may also derive from suppression of
acute inflammatory reactions. Thus, phytochemical con-
stituents of the roots are likely capable of permeating
inflamed skin to exert antimicrobial and anti-inflamma-
tory effects.
Table 1: Antimicrobial activity of the extract
Extract Concentration (mg/ml) Inhibition Zone Diameter (mm)
Ps. Aeruginosa Staph. aureus
Control - 0.0 ± 0.0 0.0 ± 0.0
AE 50 10.0 ± 0.27 10.0 ± 0.32
100 15.0 ± 0.32 19.3 ± 0.18
Gentamicin 0.7 15.0 ± 0.16 33.0 ± 0.32
AE = Aqueous Extract; n = 5; Diameter of cork borer = 6 mm; Control = DMSO (Dimethylsulphoxide)
Table 2: Effect of extract on topical acute edema of the mouse 
ear
Extract Dose (mg/ear) Edema (mg) Inhibition (%)
AE 5.0 1.29 ± 0.52a 57.0
Indomethacin 5.0 1.00 ± 0.53a 66.7
Control - 3.00 ± 0.23 -
aP < 0.05 compared to control (ANOVA; LSD post hoc); AE = 
Aqueous extract;
Values of ear edema shown are Mean ± SEM (n = 10).BMC Complementary and Alternative Medicine 2008, 8:27 http://www.biomedcentral.com/1472-6882/8/27
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The acute inflammatory reaction is a physiological charac-
teristic of vascularized tissues [37] and increased vascular
permeability associated with it is known to cause exuda-
tion of fluid rich in plasma proteins including immu-
noglobulins, coagulation factors and cells into the injured
tissues with subsequent edema at the site [38,39].
Increased vascular permeability is a major feature of acute
inflammation [40] and results from contraction and sep-
aration of endothelial cells at their boundaries to expose
the basement membrane which is freely permeable to
plasma proteins and fluid [41]. In this study, the extract
moderately inhibited increased vascular permeability
induced by acetic acid in the mouse peritoneum. Acetic
acid causes an immediate sustained reaction that is pro-
longed over 24 h [12,40] and the inhibition caused by the
extract suggests it may suppress exudation and its conse-
quences and thus modulate the magnitude of the inflam-
matory response associated with boils. On the
proliferative phase of inflammation, the extract was not
effective in ameliorating the overall outcome of formalde-
hyde arthritis event notwithstanding the fact that it inhib-
ited the early stages (which is likely an extension of its
effect on acute inflammation). The usefulness of the
extract may be limited to acute inflammatory conditions
such as obtained in boils and which is consistent with the
ethnomedicinal use of the plant roots. As such, the extract
may not offer any relief when used in disorders of chronic
inflammation such as rheumatoid arthritis.
Another key aspect of the inflammatory response is cellu-
lar infiltration due to the pivotal role played by leukocytes
in inflammation. These cells are found in boil cavities
where the dead cells and necrotic tissues form compo-
nents of pus [13]. As part of their defensive roles during
inflammation, these cells release their lysosomal contents
such as bactericidal enzymes and proteases, at sites of
inflammation which cause further tissue damage and
inflammation [42]. Stabilization of the membranes of
these cells inhibits lysis and subsequent release of the
cytoplasmic contents which in turn limits the tissue dam-
age and exacerbation of the inflammatory response. In
vitro assessment of the effect of the extract on membrane
stabilization showed that it inhibited heat- and hypoto-
nicity-induced lysis of ox red blood cells. Although we do
not know the precise mechanism of membrane stabiliza-
tion in this case, direct interaction of constituents of the
extract with membrane components such as proteins
seems most probable. Membrane proteins are largely
responsible for the physical properties of the cell mem-
brane and may contribute to the regulation of the volume
and water content of cells by controlling the movement of
sodium and potassium ions [43] through the protein
channels which make up ion channels in the cell mem-
brane [13]. Since pathological conditions can alter sur-
face-volume ratio of the cell through loss of membrane
surface or gain in volume [43], the physical integrity of the
treated cell membranes may have been enhanced by the
extract (through a direct protective interaction with the
membrane proteins) to hinder cell lysis including that
caused by products such as those of the complement sys-
tem involved in the inflammatory response cascade and
hypotonic solutions that cause the cell to swell and rup-
ture [43]. The stability of biological membranes is also
Table 3: Effect of extract on agar-induced acute edema of the rat paw
Extract Dose (mg/kg) Edema (ml)
0.5 h 1 h 2 h 3 h 4 h 5 h
AE 200 0.14 ± 0.02 
(33.33)
0.14 ± 0.02* 
(44.00)
0.15 ± 0.02* 
(51.61)
0.14 ± 0.02* 
(58.82)
0.19 ± 0.07* 
(57.78)
0.20 ± 0.07* 
(58.33)
400 0.16 ± 0.02 
(28.81)
0.16 ± 0.02* 
(36.0)
0.18 ± 0.03* 
(41.94)
0.18 ± 0.04* 
(47.06)
0.26 ± 0.08* 
(42.22)
0.35 ± 0.05 
(27.08)
800 0.16 ± 0.02 
(28.81)
0.18 ± 0.03* 
(28.00)
0.23 ± 0.06 
(25.81)
0.26 ± 0.07 
(23.53)
0.31 ± 0.06 
(31.11)
0.36 ± 0.06 
(25.0)
Indomethacin 100 0.16 ± 0.01 
(28.81)
0.18 ± 0.03* 
(28.00)
0.18 ± 0.03* 
(41.94)
0.21 ± 0.03* 
(38.24)
0.29 ± 0.04 
(35.56)
0.30 ± 0.04* 
(37.50)
Control - 0.21 ± 0.01 0.25 ± 0.00 0.31 ± 0.01 0.34 ± 0.01 0.45 ± 0.03 0.48 ± 0.01
*Reduction in edema significant at P < 0.05 compared to control (ANOVA; LSD post hoc). Values of edema shown are Mean ± SEM (n = 5); AE = 
Aqueous extract; Values in parenthesis represent percent inhibition of edema calculated relative to the Control.
Table 4: Effect of extract on global edematous response to 
arthritis induced by formaldehyde
Extract Dose (mg/kg) AUC (ml/day) Inhibition (%)
AE 200 2.93 ± 0.41 NI
400 2.66 ± 0.09 NI
800 2.69 ± 0.52 NI
Indomethacin 100 1.85 ± 0.23 28.84
Control - 2.60 ± 0.06 -
Values of AUC shown are Mean ± SEM (n = 5); AE = Aqueous 
extract;
NI = No inhibitionBMC Complementary and Alternative Medicine 2008, 8:27 http://www.biomedcentral.com/1472-6882/8/27
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affected by reactive oxygen species and we have in an ear-
lier study (data not shown) shown that the extract exhib-
ited antioxidant effect by inhibiting lipid peroxidation
induced by CCl4 and ferrous sulphate in the rat kidney
and liver [44]. This action suggests that the extract may
enhance membrane stability through antioxidant effect
and protect the tissues from damage due to injurious
products of oxidative stress implicated in the pathogenesis
of inflammatory disorders [45]. Furthermore, inhibition
of cell migration or infiltration is associated with anti-
inflammatory effect. Cellular migration involves a
sequence of well-documented events [46-49]. Expression
of chemoattractant factors and response of these cells to
chemotactic signals are central to their migration. In addi-
tion to enhancing neutrophil migration, chronic adminis-
tration of the extract to mice increased the population of
macrophages which migrated to the peritoneum in
response to stimulation. These independent but related
tests confirm that the root extract may stimulate or
enhance cellular migration. However, the extent of inter-
action of the extract with the processes associated with cell
recruitment is not known to us. Like neutrophils, macro-
phages also migrate in response to chemotactic factors
and the enhancement of their migration by the extract
may involve similar mechanisms. Since inhibition of cell
migration is known to contribute to anti-inflammatory
activity, enhancement or stimulation of migration by the
extract runs counter to the anti-inflammatory activity. Our
result also showed that increasing the dose of the extract
reduced the extent or magnitude of cell migration which
suggests that the extract may as well inhibit cell migration
under acute inflammatory response. However, the occur-
rence of this effect only at high doses not likely employed
in traditional use of the roots in treatment of boils indi-
cates that inhibition of cell migration may not contribute
to the anti-inflammatory effect and most unlikely to play
any role in the relief obtained. Thus, although anti-
inflammatory effect may relieve the discomfort caused by
boils, constituents of roots of this plant may owe part of
their action in furuncles to a more fundamental mecha-
nism the magnitude of which may be dependent on the
extent of cell migration which they appear to enhance.
In furtherance of their defensive roles at sites of infection,
leukocytes engage in phagocytosis to contain the micro-
bial invasion. Evaluation of the effect of the extract on
phagocytosis showed that it enhanced the phagocytic
activity of mouse peritoneal macrophages quantified as
increase in the number of macrophages that ingested C.
albicans. The phagocytic activity of these cells also results
to the generation of the necrotic tissue debris and dead
cells known to be components of pus [13] and may be the
major mechanism responsible for the acceleration of pus
formation seen when the root is used in the treatment of
boils. In addition to phagocytic activity, we also studied
the effect of the extract on specific immune responses
mediated by the T lymphocytes which is important for
host defense against intracellular parasites [50]. Our
results showed that the extract inhibited the development
of DTHR induced by SRBCs in rats. The DTHR is charac-
terized by a heavy infiltration of T cells and macrophages
[14] in response to antigenic stimulation which in this
case was the SRBCs. Inhibition of T lymphocyte infiltra-
tion seems to contradict the enhancement of leukocyte
migration earlier noted. The disparity in the effect of the
extract on cell types may lie in the mechanisms involved
in the migration of these different species of leukocytes.
Neutrophils migrate in response to chemoattractant gradi-
Table 5: Effect of extract on acetic acid-induced vascular permeability
Extract Dose (mg/kg) Absorbance (610 nm) Inhibition (%)
AE 200 0.38 ± 0.04 5
400 0.36 ± 0.02 10
Indomethacin 50 0.20 ± 0.01 50
Control - 0.40 ± 0.02 -
AE = Aqueous extract; Values of absorbance shown are Mean ± SEM (n = 5)
Table 6: Effect of extract on heat- and hypotonicity-induced haemolysis of red blood cells
Extract Concentration (μg/ml) Heat-induced haemolysis (Inhibition %) Hypotonicity-induced haemolysis (Inhibition 
%)
AE 50 14 12
100 67 16
200 120 23
400 400 45
Hydrocortisone 50 50 97.5
n = 5; AE = Aqueous extract; Inhibition (%) of haemolysis shown was derived from absorbance valuesBMC Complementary and Alternative Medicine 2008, 8:27 http://www.biomedcentral.com/1472-6882/8/27
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ent and chemotactic factors while the migration of lym-
phocytes is stimulated by specific antigens, mitogens and
other non-specific factors produced by lymphocytes [50].
Lymphocytes though motile cells, do not respond to most
of the chemotactic factors that act on polymorphonuclear
leukocytes and macrophages [50]. Consequently, we may
safely assume that the extract promotes the expression of
chemotactic/chemoattractant factors although we do not
know its extent of interaction with processes involved in
antigen recognition which is the initial stimulus for T cell
activation [14]. This makes it also most likely that phyto-
chemical constituents of the root responsible for its effec-
tiveness in furuncle treatment may largely interfere with
or suppress immune processes with other mechanisms
such as antimicrobial and anti-inflammatory activities
playing supportive roles.
The phytochemical constituents responsible for these
activities are yet to be identified. The pharmacological
actions of the saponins [8] and the gammaceranes- acan-
thusol and its 3-O-β-D-glucopyranoside [9] isolated form
this plant are not known as well as their roles in the activ-
ities studied. Phytochemical analysis of the root extract
revealed an abundant presence of alkaloids and carbohy-
drates while saponins, glycosides, and terpenoids
occurred moderately. The relatively high presence of alka-
loids and carbohydrates suggests that these constituents
may largely account for the pharmacological activities of
the plant roots.
Oral and intraperitoneal administration of the extract to
mice caused no deaths at doses ranging from 10–5000
mg/kg suggesting an oral and i.p LD50 greater than 5000
mg/kg. The high LD50 value implies a remote risk of acute
intoxication and a high degree of relative safety independ-
ent of route of administration. Although the roots are
used externally, the relative safety is obviously advanta-
geous since systemic administration and or systemic
absorption of the root extract from site of topical applica-
tion (as employed in ethnomedicine) may pose no risk of
acute toxicity.
Conclusion
The results of this study showed that the effectiveness of
roots of A. montanus in the treatment of boils may derive
largely from enhancement of cellular migration as well as
phagocytic activity which are involved in the non-specific
defense of the body from infection while antimicrobial
and anti-inflammatory (mediated through inhibition of
increase in vascular permeability and membrane stabiliza-
tion) activities may play contributory roles. The results
further provide a rationale for the use of the roots in treat-
Table 7: Effect of extract on leukocyte and macrophage migration in vivo
Extract Dose (mg/kg) Leukocyte Count Macrophage Count (Cells/High Power Field)
TLC × 103 (Cells/ml) Neutrophil Count (%)
Control - 3.30 ± 1.6 55.0 ± 5.5 6.33 ± 0.88
AE 200 10.9 ± 3.2 (230.30) 73.0 ± 9.6 (32.73) 7.97 ± 0.38 (26.5)
400 10.0 ± 3.2 (203.03) 69.7 ± 12.0 (26.73) 9.53 ± 1.92 (50.8)
800 3.97 ± 2.4 (20.30) 52.7 ± 99.0 (-4.18) 14.20 ± 2.62* (125.4)
Levamisole 2.5 1.77 ± 0.3 (-46.36) 40.0 ± 6.2 (-27.27) NT
Metronidazole 300 NT NT 9.75 ± 0.9 (54.03)
TLC = Total Leukocyte Count; Macrophage Count = Total number of cells per high power field; Values in parenthesis represent the percent 
migration of cells; NT = Not tested; AE = Aqueous extract; *P < 0.05 compared to Control (ANOVA; LSD post hoc)
Table 8: Effect of extract on phagocytic activity of peritoneal macrophages
Extract Dose (mg/kg) Macrophage Count Macrophage phagocytic activity
Free Cells Proportion of 
free cells (%)
Cells with ingested 
C. albicans
Proportion of cells with 
ingested C. albicans(%)
Control - 6.33 ± 0.88 5.3 ± 0.88 84.13 1.00 ± 0.0 15.87
AE 200 7.97 ± 0.38 6.1 ± 0.29 76.53 1.87 ± 0.13 23.46
400 9.53 ± 1.92 7.3 ± 1.57 76.84 2.20 ± 0.42 23.16
800 14.20 ± 2.62* 9.3 ± 0.75* 65.49 6.10 ± 3.02* 42.96
Metronidazole 300 9.75 ± 0.9 4.25 ± 0.14 43.59 5.50 ± 0.43* 56.41
AE = Aqueous Extract; Values of macrophage count shown are Mean ± SEM calculated per high power field (n = 3 determinations); Values in 
parenthesis represent percentage increase in number of macrophages calculated relative to control; Proportion (%) of free cells (cells without C. 
albicans) and cells with ingested C. albicans were calculated relative to the total number of macrophages; *P < 0.05 compared to control (ANOVA; LSD 
post hoc).BMC Complementary and Alternative Medicine 2008, 8:27 http://www.biomedcentral.com/1472-6882/8/27
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ment of boils. Phytochemical constituents such as alka-
loids and carbohydrates may be responsible for these
activities. Biological activity-guided fractionation of the
aqueous extract is ongoing for isolation of the anti-
inflammatory principle.
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